Fda Questions Safety Of Experimental Diabetes Drug

Federal health regulators have concerns about bladder and breast cancer seen in patients taking an experimental diabetes pill from Bristol-Myers ...

RELATED ARTICLES
  • Cancer Physicians Attack High Drug Costs
    More than 100 cancer specialists have banded together to persuade pharmaceutical companies to bring prices down, suggesting that the high prices for medicine needed to keep someone alive is profiteering. More
  • Swedish police find drugs on Bieber tour bus
    The latest chapter in Justin Bieber's European tour escapade was added Thursday when Swedish police said they had found drugs and a stun gun on the pop singer's bus. Lars Bystrom, spokesman for the Stockholm police, told The Associated Press a small amount of drugs and a stun gun were discovered during a search of the bus, which had been parked under the Globen concert venue in Stockholm, where Bieber was performing Wednesday. More
  • Patients’ Genes Seen as Future of Cancer Care
    Major academic medical centers in New York and around the country are spending and recruiting heavily in what has become an arms race within the war on cancer. The investments are based on the belief that the medical establishment is moving toward the routine sequencing of every patient’s genome in the quest for “precision medicine,” a course for prevention and treatment based on the special, even unique characteristics of the patient’s genes. More
  • DealBook: Rising Bank Profits Tempt a Push for Tougher Rules
    Steady earnings growth on Wall Street could embolden the lawmakers and regulators who want to overhaul the banking system. More
  • Even after melanoma, some people keep on using tanning beds
    You would think that people who were diagnosed with melanoma -- the most deadly form of skin cancer -- would be meticulously careful about using sunscreen, avoiding tanning salons and generally protecting their skin. More
BING NEWS:
  • FDA Delays Afrezza Decision by Three Months, MannKind Shares Slump
    Quotes delayed at least 15 minutes. Real-time quotes provided by BATS BZX Real-Time Price. Market Data provided by Interactive Data (Terms & Conditions). Powered and Implemented by Interactive Data ...
    04/6/2014 - 1:00 pm | View Link
  • FDA staff review raises questions about MannKind diabetes device
    WASHINGTON, March 28 (Reuters) - An initial review of MannKind Corp's experimental inhaled insulin device, Afrezza, by U.S. Food and Drug Administration staff raised multiple questions about its ...
    03/28/2014 - 9:00 am | View Link
  • FDA staff review raises questions about MannKind diabetes device
    WASHINGTON (Reuters) - A review of MannKind Corp’s experimental inhaled insulin device by U.S. Food and Drug Administration staff raised questions about its safety and effectiveness ... one for Type 1 ...
    03/28/2014 - 7:50 am | View Link
  • J&J's diabetes drug passes FDA panel test despite safety concerns
    An agency advisory committee backed approval of the company's experimental diabetes ... Yet J&J faces questions about cardiovascular risks to patients on the drug. The FDA panel voted 8-7 that ...
    01/11/2013 - 12:26 am | View Link
  • FDA panel backs novel diabetes pill from J&J
    WASHINGTON (AP) -- A panel of federal health experts ruled Thursday that an experimental diabetes drug from Johnson & Johnson is safe and effective, though lingering safety questions must be tracked ...
    01/10/2013 - 9:51 am | View Link
  • More

 

Comment On This Story

Welcome to Wopular!

Welcome to Wopular

Wopular is an online newspaper rack, giving you a summary view of the top headlines from the top news sites.

Senh Duong (Founder)
Wopular, MWB, RottenTomatoes

Subscribe to Wopular's RSS Fan Wopular on Facebook Follow Wopular on Twitter Follow Wopular on Google Plus

MoviesWithButter : Our Sister Site

More Living News